female infertility. female infertility
Conditions
Interventions
Intervention 1: for case group: Subcutaneous heparin 5000 units daily for 15 days from the day of recieving ovoola. Intervention 2: For control group: no anticoagulants.
Treatment - Drugs
for case group: Subcutaneous heparin 5000 units daily for 15 days from the day of recieving ovoola
For control group: no anticoagulants.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: (to have a history of at least two well-grade embryo implantation failures; to be under 40 years old; not to have coagulopathy or any hormonal, imunologic disorder of any kind; to have normal uterine lumen) Exclusion criteria: (women who have a medical condition which needs to be treated with anti-coagulants; clear evidence of implantation failure such as hydrosalpinx, submucusal myomas, lack of well-graded, A and B, embryos to be transferred)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Implantation rate. Timepoint: 15 days after recieving the ovoola. Method of measurement: Blood beta-HCG level. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAllahverdi Chalabizadeh
Tabriz University of Medical Sciences
Outcome results
None listed